NICE INSIGHT REPORT
Messenger Ribonucleic Acid, mRNA:Market Insight, CDMO Pricing and Competitor Benchmarking
Updated Monthly
2025 CDMO pricing data for 39 clinical and commercial mRNA development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 75 CDMOs specializing in mRNA development and manufacturing
Technical focus on mRNA stability, scaling, processing, and purification technologies
Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming mRNA-based trials, sourced from the FDA Clinical Trials Database
Key market insights for innovators, CDMOs, and investors in the mRNA industry. Mix and match subscriptions to fit your organization's goals.
Trends & Opinions
Immediate access to Nice Insight's mRNA Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
Clinical Trials Landscape
Access to Nice Insight's mRNA Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming mRNA trials.
CDMO Pricing
Access to Nice Insight's mRNA CDMO Pricing Data, including price breakdowns for over 35 distinct outsourcing RFP service line items.
CDMO Profiles & Capacity
Access to Nice Insight's mRNA CDMO Directory, including capabilities for more than 70 mRNA outsourcing organizations across North America, Europe, and Asia.
Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.
Master the mRNA Market, Preclinical through Commercial:
Competitive Benchmarking
75+ mRNA CDMO Profiles
Over 900 hours of data collection and analysis
with invaluable insights from industry experts
